Valeo Financial Advisors’s Q32 Bio QTTB Stock Holding History

Valeo Financial Advisors’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-19	Closed	-$3K	–	1883
2021 Q1	$3K	Buy	+19	New	+$4K	﹤0.01%	1739

Other funds holding QTTB

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Valeo Financial Advisors's QTTB Position: Q2 2021 in Review

Valeo Financial Advisors sold out of Q32 Bio (QTTB) in Q2 2021, closing a stake of 19 shares — an estimated $3K sold.

Valeo Financial Advisors first reported a position in QTTB in Q1 2021 and held it in 1 quarter. The position peaked at $3K in Q1 2021. 118 funds tracked by Wall St. Rank hold QTTB as of Q2 2021.

Valeo Financial Advisors reported no remaining Q32 Bio position as of Q2 2021 after selling out during the quarter.
Valeo Financial Advisors sold 19 Q32 Bio shares in Q2 2021, an estimated $3K.
Valeo Financial Advisors first reported a position in Q32 Bio in Q1 2021 and held it in 1 quarter.
Valeo Financial Advisors's Q32 Bio position peaked at $3K in Q1 2021.
118 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2021.

Based on Valeo Financial Advisors's 13F filing for Q2 2021, filed 22 Jul 2021.